Aquavit


Uriel Pharmacy Inc
Human Otc Drug
NDC 48951-1276
Aquavit is a human otc drug labeled by 'Uriel Pharmacy Inc'. National Drug Code (NDC) number for Aquavit is 48951-1276. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Aquavit drug includes Angelica Archangelica Root - 1 [hp_X]/1 Anise - 1 [hp_X]/1 Black Pepper - 1 [hp_X]/1 Calendula Officinalis Flowering Top - 1 [hp_X]/1 Caraway Seed - 1 [hp_X]/1 Cinchona Officinalis Bark - 2 [hp_X]/1 Equisetum Arvense Top - 1 [hp_X]/1 Ginger - 1 [hp_X]/1 Gold - 3 [hp_X]/1 Hypericum Perforatum - 3 [hp_X]/1 and more. The currest status of Aquavit drug is Active.

Drug Information:

Drug NDC: 48951-1276
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Aquavit
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Aquavit
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Uriel Pharmacy Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANGELICA ARCHANGELICA ROOT - 1 [hp_X]/1
ANISE - 1 [hp_X]/1
BLACK PEPPER - 1 [hp_X]/1
CALENDULA OFFICINALIS FLOWERING TOP - 1 [hp_X]/1
CARAWAY SEED - 1 [hp_X]/1
CINCHONA OFFICINALIS BARK - 2 [hp_X]/1
EQUISETUM ARVENSE TOP - 1 [hp_X]/1
GINGER - 1 [hp_X]/1
GOLD - 3 [hp_X]/1
HYPERICUM PERFORATUM - 3 [hp_X]/1
JUNIPER BERRY - 1 [hp_X]/1
MATRICARIA RECUTITA - 1 [hp_X]/1
MELISSA OFFICINALIS - 1 [hp_X]/1
ORIGANUM MAJORANA - 1 [hp_X]/1
PRUNUS SPINOSA BUDDING TOP - 1 [hp_X]/1
ROSE PETAL EXTRACT - 1 [hp_X]/1
ROSEMARY - 1 [hp_X]/1
SAGE - 1 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Sep, 2009
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Uriel Pharmacy Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000185375
N0000185371
N0000175629
N0000184306
M0000728
M0006342
M0016962
M0008672
M0022575
M0516536
N0000185508
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:DTN01M69SN
21C2F5E8RE
KM66971LVF
18E7415PXQ
W2FH8O2BBE
S003A158SB
1DP6Y6B65Z
C5529G5JPQ
79Y1949PYO
XK4IUX8MNB
O84B5194RL
G0R4UBI2ZZ
YF70189L0N
R40XM3HU5X
969IQC5YJU
IJ67X351P9
065C5D077J
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Non-Standardized Plant Allergenic Extract [EPC]
Non-Standardized Food Allergenic Extract [EPC]
Standardized Chemical Allergen [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Allergens [CS]
Dietary Proteins [CS]
Plant Proteins [CS]
Food Additives [CS]
Vegetable Proteins [CS]
Seed Storage Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Cell-mediated Immunity [PE]
Dietary Proteins [CS]
Food Additives [CS]
Increased Histamine Release [PE]
Non-Standardized Food Allergenic Extract [EPC]
Non-Standardized Plant Allergenic Extract [EPC]
Plant Proteins [CS]
Seed Storage Proteins [CS]
Standardized Chemical Allergen [EPC]
Vegetable Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
48951-1276-31200 LIQUID in 1 BOTTLE, DROPPER (48951-1276-3)01 Sep, 2009N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: exhaustion, convalescence, more

Product Elements:

Aquavit aquavit ambergris cardamom centaurium erythraea cinnamon clove coriander fennel fumaria officinalis flowering top lesser galangal hyssop lavandula angustifolia flower red pepper mace nutmeg orange oregano saffron thyme vanilla white pepper water glycerin sucrose anise anise angelica archangelica root angelica archangelica root black pepper black pepper prunus spinosa budding top prunus spinosa budding top calendula officinalis flowering top calendula officinalis flowering top caraway seed caraway seed matricaria recutita matricaria recutita ginger ginger equisetum arvense top equisetum arvense top juniper berry juniper berry origanum majorana origanum majorana melissa officinalis melissa officinalis rose petal extract rose petal extract rosemary rosemary sage sage gold gold hypericum perforatum hypericum perforatum cinchona officinalis bark cinchona officinalis bark

Indications and Usage:

Uses: exhaustion, convalescence, more uses: exhaustion, convalescence, more

Warnings:

Do not use section warnings: do not use if safety seal is broken or missing.

Dosage and Administration:

Dosage & administration directions: take 10 drops every hour, in acute situations, decreasing to 4 times daily. ages 2-12: 5 drops. under 2: ask a doctor.

Package Label Principal Display Panel:

Principal display panel aquavitliquid

Further Questions:

Questions section questions? call 866.642.2858 made with care by uriel, east troy, wi 53120 www.urielpharmacy.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.